SCHEMBL25056502

SCHEMBL25056502

CSNc1ccccc1Nc1nc(Cl)ncc1Br

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 8/20 0.51
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
ALK Q9UM73 4/20 0.43
CDK19 Q9BWU1 2/20 0.43
LRRK2 Q5S007 1/20 0.39
MAPK8 P45983 3/20 0.39
MAPK9 P45984 1/20 0.37
MAPK10 P53779 1/20 0.37
CDC7 O00311 1/20 0.35
DAPK3 O43293 1/20 0.35
JAK2 O60674 1/20 0.35
ROCK2 O75116 1/20 0.35
PRKD3 O94806 1/20 0.35
MAP4K4 O95819 1/20 0.35
PAK4 O96013 1/20 0.35
PIM1 P11309 1/20 0.35
PRKACA P17612 1/20 0.35
CDK2 P24941 1/20 0.35
SYK P43405 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30833716 0.84 IGF1R (0.52) IGF1RKMT2AMEN1ALKCDK19
SCHEMBL4025891 0.84 IGF1R (0.52) IGF1RKMT2AMEN1ALKCDK19
SCHEMBL25056242 0.80 IGF1R (0.48) IGF1RKMT2AMEN1ALKCDK19
SCHEMBL600898 0.78 GLO1 (0.51) IGF1RKMT2AMEN1ALKCDK19
SCHEMBL30833802 0.78 IGF1R (0.55) IGF1RKMT2AMEN1ALKCDK19
SCHEMBL24260666 0.78 IGF1R (0.55) IGF1RKMT2AMEN1ALKCDK19
SCHEMBL17544687 0.78 IGF1R (0.55) IGF1RKMT2AMEN1ALKCDK19
SCHEMBL25056307 0.78 MEN1 (0.52) IGF1RKMT2AMEN1ALKCDK19
SCHEMBL21557746 0.78 IGF1R (0.51) IGF1RKMT2AMEN1ALKCDK19
SCHEMBL2843128 0.78 ALK (0.58) IGF1RKMT2AMEN1ALKCDK19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4137484-A1 TRICYCLIC COMPOUNDS AS EGFR INHIBITORS QILU PHARMACEUTICAL CO., LTD. (CN) 2023-02-22 EP disclosed